My ePortfolio Register   
 

Abstract | Full HTML Article | PDF | Portuguese ecancer 10 681 / DOI: 10.3332/ecancer.2016.681

Policy

Phosphoethanolamine and the danger of unproven drugs

The use of unproven forms of therapy in cancer treatment is very common. In Brazil, the distribution by researchers to patients of an investigational agent called phophoethanolamine (PHOS) has led to a widely publicized scientific scandal. PHOS is a precursor to components of the cell membrane, with some published pre-clinical studies suggesting cytotoxic activity in cancer cells. The willingness of courts and of legislators to guarantee access to PHOS in spite of the lack of any clinical data and against the recommendations of scientific and medical organisations underscores the risks that unproven agents pose to regulatory authorities, health care systems and patients, and bears resemblance to other cases such as the controversy surrounding the approval of zidovudine for AIDS treatment by the FDA.

Keywords: phosphoethanolamine, cancer, science, Brazil, ethics

Loading Article Metrics ... Please wait

Related articles

Review: Gastric cancer and related epigenetic alterations

Abstract | Full Article | PDF Published: 17 Jan 2017 / DOI: 10.3332/ecancer.2017.714

Research: Estimation of life expectancy of patients diagnosed with the most common cancers in the Valparaiso Region, Chile

Abstract | Full Article | PDF Published: 17 Jan 2017 / DOI: 10.3332/ecancer.2017.713

Policy: The impact of the EU general data protection regulation on scientific research

Abstract | Full Article | PDF Published: 03 Jan 2017 / DOI: 10.3332/ecancer.2017.709

Special Issue: The current situation for gastric cancer in Chile

Abstract | Full Article | PDF | Spanish Published: 21 Dec 2016 / DOI: 10.3332/ecancer.2016.707

Special Issue: Central nervous system metastasis secondary to colorectal cancer: a retrospective cohort study of 20 cases

Abstract | Full Article | PDF | Spanish Published: 21 Dec 2016 / DOI: 10.3332/ecancer.2016.705



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence